Pharmaceuticals & Biotechnology

By Jim Sabogal | Using #clinicaltrials to make #medicines for #pharma and #biotech

Parkinson's: How a 'bad' enzyme might protect the brain

A recent study could change our understanding of the ways in which mitochondria, or the powerhouses of the cells, influence Parkinson's disease. The …

Neuroscience

At J.P. Morgan, A Sense That The Long-Promised Biotech Future Has Arrived; Is Tech Disruption Next?

Given the size and scope of the annual J.P. Morgan (JPM) Healthcare meeting (I resisted the temptation to say “diversity”), everyone in town – the minority who actually attend the formal presentations, and the many others who show up in San Francisco to meet and network – comes away with a slightly …

Innovation

How pharma can accelerate business impact from advanced analytics

Savvy pharma companies follow these five principles to scale analytics and improve their bottom line.<p><b>Once upon a time,</b> a biopharmaceutical company …

Pharma

10 Blockbuster Drugs of the Future

The pharmaceutical industry occasionally hits a home run by creating a drug that generates sales in excess of $1 billion per year – the watermark for …

Biggest Blockbuster Drugs of All Time

Lipitor, Humira and Advair boosted the bottom lines of Big Pharma companies and their shareholders for years.<p>A prescription drug that surpasses $1 …

Pharma

U.S. FDA approves new diabetes drug from Merck and Pfizer

(Reuters) - A new drug developed by Merck & Co and Pfizer Inc won U.S. approval on Wednesday to treat type II diabetes, the Food and Drug Administration said, adding another competitor to a growing class of treatments.<p>The oral drug, known generically as ertugliflozin, will be sold under the brand …

Pharma

Experts Tell Congress How To Cut Drug Prices

The nation’s most influential science advisory group will tell Congress today that the U.S. pharmaceutical market is not sustainable and needs to …

Winning Health Tech Entrepreneurs Will Focus On Implementation, Not Fetishize Invention

One word: implementation.<p>Increasingly, I’m convinced that the underappreciated challenges of implementation describe the ever-expanding gap between the promise of emerging technologies (sensors, AI) and their comparatively limited use in clinical care and pharmaceutical research. (Updated …

Digital Health

Merck raises stakes in lung cancer as rivals close in

LOS ANGELES (Reuters) - Merck & Co Inc, maker of the only immunotherapy approved for patients newly-diagnosed with the most common type of lung cancer, could solidify its lead by playing the long game, even as rivals edge closer.<p>Shares of Merck have fallen 10 percent since the drugmaker several …

Cancer

Viagra Goes Generic: Pfizer to Launch Own Little White Pill

The little blue pill that's helped millions of men in the bedroom is turning white. Drugmaker Pfizer is launching its own cheaper generic version of …

Everything You Need to Know About Crispr Gene Editing

In the last five years, biology has undergone a seismic shift as researchers around the globe have embraced a revolutionary technology called gene …

Genetics

Amazon is reportedly talking to generic drug companies

Amazon is talking with generic drug makers about possibly entering the health care market, reports CNBC. Anonymous sources say the company has had “high-level” talks with pharmaceutical company Mylan and the Sandoz division of Novartis, both of which produce large numbers of generic drugs. A note …

Generic Drugs

Top 10 Pharma Companies of 2017 | The Lists | GEN

While biotech stocks ran into the headwinds of disappointing results and clinical trial failures during the third quarter, leading to talk of a …

Fighting Cancer One Patient At A Time

Allan Brandt, a 63-year-old history of medicine professor at Harvard, seems taken aback to have become part of medical history himself. In 2012, he was diagnosed with acute myeloid leukemia, a deadly cancer that had a potential cure: a bone marrow transplant. His sister was a match, and he went …

Cancer

Avoiding Counterfeit Pills in the Age of Big Pharma

Chris Crepeau couldn't understand why he felt the way he did.<p>As usual, the New Jersey man took his daily dose of Lipitor for high cholesterol. Still, …

Cancer drug shows unexpected fat-melting side effects

A drug developed originally to treat breast cancer and diabetes has been found to offer an unexpected and beneficial side effect. Scientists have …

Medicine

The Precision Medicine Stock That's Revolutionizing Cancer Treatment

Cancer treatment is moving rapidly toward personalized medicine and precision medicine thanks to genetic insight.<p><b>Foundation Medicine</b>'s (NASDAQ:FMI) …

Gene editing remains early stage, but Big Pharma has taken notice

Gene editing offers near-limitless medical potential. The challenge is putting it into medical practice. So how is gene editing progressing, in terms …

Medical Technology

Innovating at the speed of the 21st century in pharmaceuticals

The CEO of Eli Lilly offers perspectives on accelerating change in the industry.<p><i>Eli Lilly and Company is an innovation-driven biopharmaceutical</i> …

Innovation

More evidence emerges for Amazon's push into pharmacy industry

The e-commerce giant has obtained pharmaceutical distribution licenses in 12 US states.<p>New evidence emerged Friday that Amazon may have its sights set on the drug industry.<p>According to public records dug up by the St. Louis Post-Dispatch, Amazon has obtained approval to be a wholesale distributor …

Amazon

CRO Consolidation: A Sinister Threat Or Windfall For Pharma?

The drug development process is fraught with complexities and challenges, with delays and cost overruns being a commonplace occurrence. In-human clinical trials represent the final endgate satisfying regulatory agency concerns over efficacy and safety while being the costliest phase of bringing a …

Pharma

FDA Approves Another Amazing And Costly Cancer-Killing Gene Therapy

In 2010, Josh Feldman was on his honeymoon — a globe-spanning trip that at one point involved swimming with humpback whales — when he noticed a “Garbanzo-sized” lump on the back of his neck. It turned out to be lymphoma, which worsened even as he cycled through treatments: chemotherapy, the …

Cancer

Tiny Ignyta's Lung Cancer Drug Bested Pfizer's. Probably. Will We Ever Know For Sure?

There should have been a drug to prolong Stuart Brown’s life. But when his first option failed him, it seemed there was nothing else to try.<p>Then came a drug made by Ignyta Pharmaceuticals, a San Diego-based drugmaker, that shrank his tumors and has kept them in check for more than a year. Results …

Cancer

Doctors With Strong Financial Ties To Pharma Are Found More Likely To Prescribe Brand-Name Drugs

Generic cholesterol pills are probably better for most patients than brand-name medications because the lower cost of generics increases the chance the patients will take the pills every day.<p>Yet some physicians primarily prescribe expensive brand-name drugs like Lipitor and Crestor. According to a …

Pharma

Viruses discovered a century ago may be our best defense against a threat that could kill 10 million people a year by 2050

Antibiotic resistance — the phenomenon in which bacteria stop responding to certain antibiotics — is a growing threat around the world.<p>It's expected to kill 10 million people annually by 2050.<p>And it hasn't been easy to develop new drugs in order to stay ahead of the problem. Many major …

Medicine

Biotech, Brexit and big data: Nathalie Moll on the state of Europe’s pharma industry

Nathalie Moll is the newly appointed director general of the European Federation of Pharmaceutical Industries and Associations (EFPIA), assuming the …

Digital Health

A biotech backed by Bill Gates is developing therapies that could treat everything from skin diseases to cancer

A Chicago-based biotech that's backed by Bill Gates wants to build treatments that can silence genes to treat diseases like cancer.<p>In September, Exicure, led by 36-year-old David Giljohann, raised $20 million from investors including Gates, AbbVie Ventures, Groupon cofounder Eric Lefkofsky, and …

Big Pharma Creating Startup Firms to Do Drug Research

Pharmaceutical companies are trying to capture a little bit of the startup magic.<p>Pfizer and several other firms have invested in a small spinoff …

Pharma

3 Big Pharma Stocks Set to Succeed

Solid current franchises and strong pipelines could make these three big pharma stocks big winners in coming years.<p>That disclaimer that the …

Stocks